Immunological Predictors of Post Infectious Inflammatory Response Syndrome in HIV-Negative Immunocompetent

Yijie Wang1, Hang Wei2, Liping Shen1

  • 1Department of Neurology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Abstract

Insights

Serum immune factors like IL-6 and IgM, along with neutrophil levels, can help predict post-infectious inflammatory response syndrome (PIIRS) in cryptococcal meningitis (CM) patients. These markers offer valuable insights for early detection and management.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Cryptococcal meningitis (CM) can lead to post-infectious inflammatory response syndrome (PIIRS) in immunocompetent individuals.
  • Identifying predictors for PIIRS is crucial for timely intervention and improved patient outcomes.

Purpose of the Study:

  • To investigate the correlation between serum immune factors and PIIRS in immunocompetent CM patients.
  • To determine if serum immune factors can predict the development of PIIRS.

Main Methods:

  • A cohort study involving 347 CM patients, with 30 diagnosed with PIIRS.
  • Analysis of clinical data and immunological indexes including cytokines, complement, and immunoglobulins.
  • Statistical methods included Spearman correlation, principal component analysis, random forest classification, and survival analysis.

Main Results:

  • Patients with PIIRS exhibited lower baseline serum interleukin-6 (IL-6) and immunoglobulin M (IgM), and a higher neutrophil ratio compared to those without PIIRS.
  • Neutrophil ratio, IgM, and IL-6 showed significant correlations with PIIRS.
  • A predictive model combining neutrophil ratio, neutrophil count, IgM, IL-6, and D-dimer achieved 75% accuracy, with an AUC of 0.76 and sensitivity of 70%.

Conclusions:

  • Baseline neutrophil ratio, neutrophil count, IgM, IL-6, and D-dimer are potential clinical predictors for PIIRS in HIV-negative immunocompetent CM patients.
  • These markers may aid in the early identification and management of PIIRS, potentially improving patient prognosis.